Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Verve Therapeutics Inc (NQ: VERV )

22.68 +0.11 (+0.49%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 631,138
Open 22.67
Bid (Size) 20.51 (5)
Ask (Size) 23.00 (5)
Prev. Close 22.57
Today's Range 21.71 - 22.99
52wk Range 10.70 - 43.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Being Cautious On Regulatory/Commercial Path, This Analyst Initiates Coverage On Verve Therapeutics
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
 
Via Benzinga

Performance

YTD
+20.00%
+20.00%
1 Month
+12.39%
+12.39%
3 Month
+10.20%
+10.20%
6 Month
-19.97%
-19.97%
1 Year
-18.42%
-18.42%

More News

Read More
7 CRISPR Stocks With the Best Long-Term Potential
Via InvestorPlace
Why Verve Therapeutics' Stock Dropped 26.33% on Monday
Via The Motley Fool
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
Via Benzinga
Verve Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Verve Therapeutics
Via Globe NewsWire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023?
Via Investor's Business Daily
Analyst Beefs Up Beam Therapeutics Price Target, Says 'Reward Is Now Skewed To Upside'
Via Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
Via Benzinga
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Gold Down 1%; China Pharma Shares Spike Higher
Via Benzinga
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
US Stocks Start Week On Lower Note; Dow Tumbles 250 Points
Via Benzinga
Verve Therapeutics Stock Skids On The FDA's Long List Of Gene-Editing Concerns
Via Investor's Business Daily
Looking Into Verve Therapeutics's Recent Short Interest
Via Benzinga
Verve Therapeutics to Participate in Upcoming Investor Conferences
From Verve Therapeutics
Via Globe NewsWire
Dow Surges 400 Points; Crude Oil Down 1%
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Looking Into Verve Therapeutics's Recent Short Interest
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.